Terra Innovatum Global N.V. (NKLR) SEC Filings & Earnings Calls
EquiReason read 11 Terra Innovatum Global N.V. SEC filings in the last 12 months. Latest: 8-K on 2026-10-16 — Terra Innovatum Global N.V. dismissed KPMG and engaged MaloneBailey as its independent registered public accounting firm, citing no disagreements but noting unremediated material w.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 223.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
16 Oct 20268-K · 4.01Terra Innovatum Global N.V. dismissed KPMG and engaged MaloneBailey as its independent registered public accounting firm, citing no disagreements but noting unremediated material weaknesses in internal controls.open
Risks flagged
Unremediated material weaknesses in internal control over financial reporting
“The material weaknesses have not been remediated.” · word for word
14 Aug 202610-QNet loss widened to $18,044 in Q2 2026 from $1,145 in Q2 2025 due to higher operating expenses and non-cash fair value losses.earningsopen
Figures in the filing · each found in the filing text
| Cash and cash equivalents · Q2-2026 | $91M | |
| Net loss · Q2-2026 | $18M | |
| General and administrative expenses · Q2-2026 | $5M | |
| Development costs · Q2-2026 | $1M | |
| Accumulated deficit · Q2-2026 | $632M |
Risks flagged
Pre-revenue development stage
“The Company has not yet constructed a commercial reactor and has not generated revenue from operations.” · word for word
Cash burn and going concern
“Net cash used in operating activities was $8,778 for the six months ended June 30, 2026.” · word for word
Regulatory approval risk
“The regulatory approval process for nuclear technologies is complex, time-consuming, and subject to factors beyond the Company’s control.” · word for word
Material weaknesses in internal controls
“We did not maintain effective internal controls over financial reporting, which resulted in deficiencies in principles associated with the control environment.”
1 Jul 202610-QNet loss widened to $7,106 in Q1 2026 from $1,448 in Q1 2025 due to higher operating expenses and non-cash fair value losses.earningsopen
Figures in the filing · each found in the filing text
| Cash and cash equivalents · Q1-2026 | $97M | |
| Net loss · Q1-2026 | $7M | |
| General and administrative expenses · Q1-2026 | $5M | |
| Development costs · Q1-2026 | $1M | |
| Accumulated deficit · Q1-2026 | $614M |
Risks flagged
Pre-revenue development stage
“The Company has not yet constructed a commercial reactor and has not generated revenues from operations.” · word for word
Cash burn and going concern
“Net cash used in operating activities was $3,856 for the three months ended March 31, 2026.” · word for word
Regulatory approval risk
“The regulatory approval process for nuclear technologies is complex, time-consuming, and subject to factors beyond the Company’s control.” · word for word
Material weaknesses in internal controls
“We did not maintain effective internal controls over financial reporting, which resulted in deficiencies in principles associated with the control environment.”
16 Jun 202610-KPre-revenue nuclear developer reports net income of $539,524 for FY2025 driven by non-cash fair value gains; operating cash burn continues; no revenue guidance.earningsopen
Figures in the filing · each found in the filing text
| Cash and cash equivalents · FY2025 | $102882.00 | |
| Accumulated deficit · FY2025 | $607M | |
| Net income (loss) · FY2025 | $539524.00 | -1586935% y/y |
| Net cash used in operating activities · FY2025 | $10297.00 | +24417% y/y |
| General and administrative expenses · FY2025 | $32311.00 | |
| Number of employees · FY2025 | 5 | |
| Net proceeds from Business Combination and PIPE · FY2025 | $106713.00 |
Risks flagged
Going concern / capital adequacy
“We have incurred losses and have not generated any revenue since our inception. We anticipate that we will continue to incur losses, and expect that we will not generate revenue, for the foreseeable future.” · word for word
Regulatory approval risk
“The SOLO designs have not yet been approved or licensed for use at any site by the NRC, and approval or licensing of these designs is not guaranteed.” · word for word
Commercialization risk
“We have not yet commercialized or sold the SOLO or any other micro-modular reactor ("MMR"), and there is no guarantee that we will be able to do so.” · word for word
Supply chain concentration
“We rely on a limited number of suppliers for such materials and components, which means we may not be able to obtain sufficient raw materials or supplied components to meet our manufacturing and operating needs, or obtain such materials on favorable terms or at expected costs.” · word for word
Internal control weaknesses
“We identified material weaknesses in our internal controls over financial reporting.” · word for word
17 Nov 202510-QPost-period SPAC merger completed, providing $36.8M in PIPE proceeds and Nasdaq listing.open
Figures in the filing · each found in the filing text
| Cash and cash equivalents · Q3-2025 | $2M | |
| Accumulated deficit · Q3-2025 | $6M | |
| Net loss · Q3-2025 | $-3M | |
| Net loss · 9M-2025 | $-6M | |
| Cash used in operating activities · 9M-2025 | $-4M | |
| Bridge loans, net · Q3-2025 | $4M | |
| PIPE proceeds · Q4-2025 | $37M |
Risks flagged
Pre-revenue development stage
“To date, we have not generated any revenue from product sales and do not expect to generate any revenue from the sale of products for the foreseeable future.” · word for word
Regulatory approval dependency
“The commercial rollout of any advanced nuclear reactors depends on securing regulatory approvals for its design, construction, and operation.” · word for word
Going concern risk (mitigated)
“These conditions initially raised substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements were issued.” · word for word
Terra Innovatum Global N.V. — questions
- What did Terra Innovatum Global N.V. file recently?
- 11 SEC filings in the last 12 months. Latest: 8-K on 2026-10-16 — Terra Innovatum Global N.V. dismissed KPMG and engaged MaloneBailey as its independent registered public accounting firm, citing no disagreements but noting unremediated material weaknesses in internal controls.
Every figure on this page comes from Terra Innovatum Global N.V.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.